Abstract
Anxiety disorders (ADs) and obsessive-compulsive and related disorders (OCRDs) comprise multiple mental disorders, characterized by high levels of anxiety, dysfunctional catastrophic thoughts and most often substantial avoidance. These disorders contribute a significant burden to individual patients and society, due to high prevalence, early onset of symptoms, chronic course, high levels of impairment and high comorbidity. Although the various disorders have very specific symptom profiles, as described in the classification systems, they share phenomenological characteristics and underlying etiology and pathophysiology.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
American Psychiatric, A. Diagnostic and statistical manual of mental disorders: DSM-5. 5th ed. American Psychiatric Association; 2013. p. xliv, 947p.
World Health Organisation. International classification of diseases for mortality and morbidity statistics (11th Revision). 2018. https://icd.who.int/.
Insel T, et al. Research domain criteria (RDoC): toward a new classification framework for research on mental disorders. Am J Psychiatry. 2010;167:748–51. https://doi.org/10.1176/appi.ajp.2010.09091379.
Institute for Health Metrics and Evaluation. Global Health Data Exchange, Global Burden of Disease Results Tool. http://ghdx.healthdata.org/gbd-results-tool.
Geddes J, Andreasen NC, Goodwin G. New Oxford textbook of psychiatry. 3rd ed. Oxford University Press; 2020.
Stein DJ, et al. Obsessive-compulsive disorder. Nat Rev Dis Primers. 2019;5:52. https://doi.org/10.1038/s41572-019-0102-3.
Craske MG, et al. Anxiety disorders. Nat Rev Dis Primers. 2017;3:17024. https://doi.org/10.1038/nrdp.2017.24.
Sharma E, Thennarasu K, Reddy YC. Long-term outcome of obsessive-compulsive disorder in adults: a meta-analysis. J Clin Psychiatry. 2014;75:1019–27. https://doi.org/10.4088/JCP.13r08849.
Ormel J, Sytema S, Oldehinkel AJ. Epidemiologische aspecten van angststoornissen. In: den Boer JA, Westenberg HGM, editors. Leerboek Angststoornissen. Utrecht: De Tijdstroom; 1995.
Bandelow B, et al. Biological markers for anxiety disorders, OCD and PTSD—a consensus statement. Part I: neuroimaging and genetics. World J Biol Psychiatry. 2016;17:321–65. https://doi.org/10.1080/15622975.2016.1181783.
Welch JM, et al. Cortico-striatal synaptic defects and OCD-like behaviours in Sapap3-mutant mice. Nature. 2007;448:894–900. https://doi.org/10.1038/nature06104.
International Obsessive Compulsive Disorder Foundation Genetics, C. & Studies, O. C. D. C. G. A. Revealing the complex genetic architecture of obsessive-compulsive disorder using meta-analysis. Mol Psychiatry. 2018;23:1181–8. https://doi.org/10.1038/mp.2017.154.
Otowa T, et al. Meta-analysis of genome-wide association studies of anxiety disorders. Mol Psychiatry. 2016;21:1391–9. https://doi.org/10.1038/mp.2015.197.
Klengel T, Binder EB. Epigenetics of stress-related psychiatric disorders and gene x environment interactions. Neuron. 2015;86:1343–57. https://doi.org/10.1016/j.neuron.2015.05.036.
Licht CM, de Geus EJ, van Dyck R, Penninx BW. Association between anxiety disorders and heart rate variability in The Netherlands Study of Depression and Anxiety (NESDA). Psychosom Med. 2009;71:508–18. https://doi.org/10.1097/PSY.0b013e3181a292a6.
Bandelow B, et al. Biological markers for anxiety disorders, OCD and PTSD: a consensus statement. Part II: neurochemistry, neurophysiology and neurocognition. World J Biol Psychiatry. 2017;18:162–214. https://doi.org/10.1080/15622975.2016.1190867.
LeDoux JE, Pine DS. Using neuroscience to help understand fear and anxiety: a two-system framework. Am J Psychiatry. 2016;173:1083–93. https://doi.org/10.1176/appi.ajp.2016.16030353.
McNaughton N, Gray JA. Anxiolytic action on the behavioural inhibition system implies multiple types of arousal contribute to anxiety. J Affect Disord. 2000;61:161–76. https://doi.org/10.1016/s0165-0327(00)00344-x.
Klumpers F, Kroes MCW, Baas JMP, Fernandez G. How human amygdala and bed nucleus of the stria terminalis may drive distinct defensive responses. J Neurosci. 2017;37:9645–56. https://doi.org/10.1523/JNEUROSCI.3830-16.2017.
Lipp OV, Waters AM, Luck CC, Ryan KM, Craske MG. Novel approaches for strengthening human fear extinction: the roles of novelty, additional USs, and additional GSs. Behav Res Ther. 2020;124:103529. https://doi.org/10.1016/j.brat.2019.103529.
Kindt M, Soeter M, Vervliet B. Beyond extinction: erasing human fear responses and preventing the return of fear. Nat Neurosci. 2009;12:256–8. https://doi.org/10.1038/nn.2271.
Kida S. Reconsolidation/destabilization, extinction and forgetting of fear memory as therapeutic targets for PTSD. Psychopharmacology. 2019;236:49–57. https://doi.org/10.1007/s00213-018-5086-2.
Gillan CM, Robbins TW, Sahakian BJ, van den Heuvel OA, van Wingen G. The role of habit in compulsivity. Eur Neuropsychopharmacol. 2016;26:828–40. https://doi.org/10.1016/j.euroneuro.2015.12.033.
Boedhoe PS, et al. Distinct subcortical volume alterations in pediatric and adult OCD: a worldwide meta- and mega-analysis. Am J Psychiatry. 2017;174:60–9. https://doi.org/10.1176/appi.ajp.2016.16020201.
Goodkind M, et al. Identification of a common neurobiological substrate for mental illness. JAMA Psychiat. 2015;72:305–15. https://doi.org/10.1001/jamapsychiatry.2014.2206.
van den Heuvel OA, et al. An overview of the first 5 years of the ENIGMA obsessive-compulsive disorder working group: the power of worldwide collaboration. Hum Brain Mapp. 2020;43(1):23–36. https://doi.org/10.1002/hbm.24972.
Xu J, et al. Anxious brain networks: a coordinate-based activation likelihood estimation meta-analysis of resting-state functional connectivity studies in anxiety. Neurosci Biobehav Rev. 2019;96:21–30. https://doi.org/10.1016/j.neubiorev.2018.11.005.
Kolesar TA, Bilevicius E, Wilson AD, Kornelsen J. Systematic review and meta-analyses of neural structural and functional differences in generalized anxiety disorder and healthy controls using magnetic resonance imaging. Neuroimage Clin. 2019;24:102016. https://doi.org/10.1016/j.nicl.2019.102016.
Thorsen AL, et al. Emotional processing in obsessive-compulsive disorder: a systematic review and meta-analysis of 25 functional neuroimaging studies. Biol Psychiatry Cogn Neurosci Neuroimaging. 2018;3:563–71. https://doi.org/10.1016/j.bpsc.2018.01.009.
Norman LJ, et al. Error processing and inhibitory control in obsessive-compulsive disorder: a meta-analysis using statistical parametric maps. Biol Psychiatry. 2019;85:713–25. https://doi.org/10.1016/j.biopsych.2018.11.010.
Slee A, et al. Pharmacological treatments for generalised anxiety disorder: a systematic review and network meta-analysis. Lancet. 2019;393:768–77. https://doi.org/10.1016/S0140-6736(18)31793-8.
Cuijpers P, et al. The efficacy of psychotherapy and pharmacotherapy in treating depressive and anxiety disorders: a meta-analysis of direct comparisons. World Psychiatry. 2013;12:137–48. https://doi.org/10.1002/wps.20038.
Boedhoe PSW, et al. Cortical abnormalities associated with pediatric and adult obsessive-compulsive disorder: findings from the ENIGMA Obsessive-Compulsive Disorder Working Group. Am J Psychiatry. 2018;175:453–62. https://doi.org/10.1176/appi.ajp.2017.17050485.
Ost LG, Havnen A, Hansen B, Kvale G. Cognitive behavioral treatments of obsessive-compulsive disorder. A systematic review and meta-analysis of studies published 1993-2014. Clin Psychol Rev. 2015;40:156–69. https://doi.org/10.1016/j.cpr.2015.06.003.
Brooks SJ, Stein DJ. A systematic review of the neural bases of psychotherapy for anxiety and related disorders. Dialogues Clin Neurosci. 2015;17(3):261–79. https://doi.org/10.31887/DCNS.2015.17.3/sbrooks.
Ma Y. Neuropsychological mechanism underlying antidepressant effect: a systematic meta-analysis. Mol Psychiatry. 2015;20:311–9. https://doi.org/10.1038/mp.2014.24.
Hurlemann R, et al. Human amygdala reactivity is diminished by the beta-noradrenergic antagonist propranolol. Psychol Med. 2010;40:1839–48. https://doi.org/10.1017/S0033291709992376.
Freire RC, Cabrera-Abreu C, Milev R. Neurostimulation in anxiety disorders, post-traumatic stress disorder, and obsessive-compulsive disorder. Adv Exp Med Biol. 2020;1191:331–46. https://doi.org/10.1007/978-981-32-9705-0_18.
Ferreira S, Pego JM, Morgado P. The efficacy of biofeedback approaches for obsessive-compulsive and related disorders: a systematic review and meta-analysis. Psychiatry Res. 2019;272:237–45. https://doi.org/10.1016/j.psychres.2018.12.096.
Tolin DF, Davies CD, Moskow DM, Hofmann SG. Biofeedback and neurofeedback for anxiety disorders: a quantitative and qualitative systematic review. Adv Exp Med Biol. 2020;1191:265–89. https://doi.org/10.1007/978-981-32-9705-0_16.
Schruers K, et al. The effects of deep-brain non-stimulation in severe obsessive-compulsive disorder: an individual patient data meta-analysis. Transl Psychiatry. 2019;9:183. https://doi.org/10.1038/s41398-019-0522-6.
Gowda SM, et al. Efficacy of pre-supplementary motor area transcranial direct current stimulation for treatment resistant obsessive compulsive disorder: a randomized, double blinded, sham controlled trial. Brain Stimul. 2019;12:922–9. https://doi.org/10.1016/j.brs.2019.02.005.
Cui H, et al. Efficacy and safety of repetitive transcranial magnetic stimulation for generalised anxiety disorder: a meta-analysis. Gen Psychiatr. 2019;32:e100051. https://doi.org/10.1136/gpsych-2019-100051.
Baldermann JC, et al. Deep brain stimulation of the ventral capsule/ventral striatum reproducibly improves symptoms of body dysmorphic disorder. Brain Stimul. 2016;9:957–9. https://doi.org/10.1016/j.brs.2016.09.003.
Kinfe T, Stadlbauer A, Winder K, Hurlemann R, Buchfelder M. Incisionless MR-guided focused ultrasound: technical considerations and current therapeutic approaches in psychiatric disorders. Expert Rev Neurother. 2020;20:687–96. https://doi.org/10.1080/14737175.2020.1779590.
Noble LJ, Souza RR, McIntyre CK. Vagus nerve stimulation as a tool for enhancing extinction in exposure-based therapies. Psychopharmacology. 2019;236:355–67. https://doi.org/10.1007/s00213-018-4994-5.
Batelaan NM, et al. Risk of relapse after antidepressant discontinuation in anxiety disorders, obsessive-compulsive disorder, and post-traumatic stress disorder: systematic review and meta-analysis of relapse prevention trials. BMJ. 2017;358:j3927. https://doi.org/10.1136/bmj.j3927.
van Dis EAM, et al. Long-term outcomes of cognitive behavioral therapy for anxiety-related disorders: a systematic review and meta-analysis. JAMA Psychiat. 2020;77:265–73. https://doi.org/10.1001/jamapsychiatry.2019.3986.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2023 Springer Nature Switzerland AG
About this chapter
Cite this chapter
Fitzsimmons, S.M.D.D., Batelaan, N.M., van den Heuvel, O.A. (2023). Anxiety Disorders and Obsessive-Compulsive and Related Disorders. In: IsHak, W.W. (eds) Atlas of Psychiatry. Springer, Cham. https://doi.org/10.1007/978-3-031-15401-0_18
Download citation
DOI: https://doi.org/10.1007/978-3-031-15401-0_18
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-031-15400-3
Online ISBN: 978-3-031-15401-0
eBook Packages: MedicineMedicine (R0)